HSD17B2 and prostate carcinoma: In the present study, we also observed HSD17β2 expression at the mRNA and protein levels in the CWR22 and PC3, but not DU-145 and LNCaP, prostate cancer cell lines, and its co-expression with AS-HSD17β2 transcript(s) (Figure 6).